Sugemalimab is the world\'s first anti-PD-L1 monoclonal antibody approved for the treatment of gastric or gastroesophageal junction (G/GEJ) adenocarcinoma. The GEMSTONE-303 study results support sugem
https://iris.who.int/handle/10665/380481 TOKYO,Feb. 25,2025-- World Health Organization (WHO) Regional Office for the Western Pacific (WPRO) has released Japan\'s AMR Response 2013–2025 alongside Tok
BEIJING,Feb. 25,2025-- Baidu,Inc. (NASDAQ: BIDU and HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) ("Baidu"),a leading AI company with strong Internet foundation,today announced that Baid
SHENZHEN,China,Feb. 25,2025--Pudu Robotics,a global leader in service robotics,is revolutionizing cleanliness standards at Ryugujo Spa Hotel Mikazuki Ryugutei in Japan,a renowned Japanese hot spring
KARACHI,Pakistan,Feb. 25,2025--Kerry,a global leader in taste and nutrition,has partnered with Far Eastern Impex (FEI) to open the first international production operation for flavourings in Pakistan
SINGAPORE,Feb. 25,2025-- China Yuchai International Limited(NYSE: CYD) ("China Yuchai" or the "Company"),one of the largest powertrain solution manufacturers through its main opera
Data Monitoring Committee (DMC) has completed the first safety and efficacy assessment of the global Phase III clinical trial,recommending continued progression as planned
SHANGHAI,Feb. 25,2025-- WuXi XDC Cayman Inc. ("WuXi XDC",or the "Company",stock code: 2268.HK),a leading global CRDMO (Contract Research,Development,and Manufacturing Organization)
SHANGHAI,Feb. 25,2025-- Everest Medicines (HKEX 1952.HK,"Everest",or the "Company"),a biopharmaceutical company focused on the discovery,clinical development,manufacturing and comm
-Earnings Webinar Scheduled for 6:00 a.m. ET on March 18,2025- GUANGZHOU,China,Feb. 25,2025--HUYA Inc. ("Huya" or the "Company") (NYSE: HUYA),a leading game live streaming platform
© OfficialAffairs
